PHAT   $18.41  -1.66% Market Closed After Close 18.429 0.10%

Phathom Pharmaceuticals Inc
Total Cash 276.24M
totalCashPerShare 4.635
EBITDA -252.07M
Total Debt 506.38M
quickRatio 6.108
currentRatio 6.484
Total Revenue 9.92M
debtToEquity
Revenue/Share 0.172
ROA -0.54069
ROE
grossProfits
freeCashflow -154.15M
operatingCashflow -215.45M
earningsGrowth
revenueGrowth
grossMargins 0.80147004
ebitdaMargins 0.0
operatingMargins -10.554339
profitMargins 0.0
enterpriseValue 1.32B
forwardPE -4.084444
floatShares 48.58M
sharesOutstanding 68.29M
sharesShort 15.34M
sharesShortPriorMonth 13.73M
dateShortInterest
sharesPercentSharesOut 0.22%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.96%
Short Ratio help_outline 19.06%
shortPercentOfFloat 0.32%
impliedSharesOutstanding
bookValue -3.99
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -297.11M
trailingEps -5.18%
forwardEps -4.50%
enterpriseToEbitda -5.24
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.49 3Q 2024
institutionsCount 169
lastUpdated Sept. 16, 2024, 7:44 p.m.